BEAT-SHOCK Registry

Recruiting Observational Study
Cardiogenic Shock Myocardial Infarction (MI) Fulminant Myocarditis Acute Decompensated Heart Failure Severe Valvular Disease Post-cardiotomy Perioperative Cardiogenic Shock
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
8,000 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay * Age ≥18 years * Provision of written ICF * Clinical diagnosis of cardiogenic shock. * impaired organ perfusion due to primar…
Contacts

Jasper Boeddinghaus, PD Dr. med.

0041613287897

jasper.boeddinghaus@usb.ch

CONTACT

Gregor Leibundgut, Prof. Dr.

0041613287897

gregor.leibundgut@usb.ch

CONTACT